Skip to main content
logo
Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
0.8524
-0.0201 (-2.30%)
At close: Dec 5, 2025, 4:00 PM EST
0.8430
-0.0094 (-1.10%)
After-hours: Dec 5, 2025, 7:31 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Immuno-inflammatory Disorders Therapies
41.10M
Log In
Log In
Immuno-inflammatory Disorders Therapies Growth
13.89%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
41.10M
Log In
Log In
United States Growth
13.89%
Log In
Log In